MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$773K
Net Income
-$39,702K
Net Profit Margin
-5136.09%
EPS
-$0.73
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
773
1,034
668
683
Research and development
36,089
36,565
40,169
32,975
General and administrative
7,052
8,084
6,666
5,542
Total operating expenses
43,141
44,649
46,835
38,517
Loss from operations
-42,368
-43,615
-46,167
-37,834
Change in fair value of preferred stock tranche right liability
-
-
0*
0
Interest income
2,659
3,054
3,654
4,105
Other income (expense), net
7
-30
54*
-19
Total other income, net
2,666
3,024
3,708
4,086
Net loss
-39,702
-40,591
-42,459
-33,748
Redeemable convertible preferred stock cumulative dividends
-
-
0
0
Net loss attributable to common stockholders
-
-
-42,459
-33,748
Basic EPS
-0.73
-0.75
-0.785
-0.63
Diluted EPS
-0.73
-0.75
-0.785
-0.63
Basic Average Shares
54,567,976
54,332,319
54,091,471
53,930,946
Diluted Average Shares
54,567,976
54,332,319
54,091,471
53,930,946
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$2,659K
(-39.99%↓ Y/Y)
Other income
(expense), net
$7K
(114.00%↑ Y/Y)
Net loss
-$39,702K
(0.66%↑ Y/Y)
Total other income,
net
$2,666K
(-39.15%↓ Y/Y)
Loss from operations
-$42,368K
(4.46%↑ Y/Y)
Collaboration revenue
$773K
(-17.50%↓ Y/Y)
Total operating
expenses
$43,141K
(-4.73%↓ Y/Y)
Research and development
$36,089K
(-4.69%↓ Y/Y)
General and
administrative
$7,052K
(-4.95%↓ Y/Y)
Buy us a coffee
Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. (UPB)